Immunohistochemistry indicated that GLI1 and METTL3/14/IGF2BP2 were significantly upregulated in lung cancer tissues compared to those in paired normal tissues (Fig. 8A, B). This evidence concerns the gene IGF2BP2 and lung carcinoma.